FDA Warning Letter & Compliance Statistics 2026
Comprehensive analysis of FDA warning letters, compliance actions, and Form 483 citations — action type breakdowns, top companies, geographic distribution, and most-cited CFR violations. Sourced from official FDA compliance databases, updated regularly.
Key Figures
| Metric | Value |
|---|---|
| Total FDA compliance actions tracked | 174,866 |
| Warning letters | 174,596 |
| Actions in FY2026 | 8,732 |
| Form 483 citations tracked | 278,578 |
| Most cited CFR provision | 21 CFR 1.502(a) (4,791 citations) |
Loading compliance statistics…
Overview
A high-level snapshot of FDA compliance and enforcement activity, including warning letters, seizures, injunctions, prosecutions, and consent decrees.
Compliance Actions by Type
The FDA takes several types of enforcement actions against companies that violate regulations. Warning Letters are the most common, serving as formal notice of significant violations. Seizures, injunctions, and prosecutions represent escalating levels of enforcement.
Year-over-Year Trends
Compliance action counts by fiscal year, broken down by action type. Trends in warning letter volume often reflect shifts in FDA enforcement priorities and resource allocation.
Top Companies — Compliance Actions
The 20 companies with the most FDA compliance actions, including warning letters, seizures, injunctions, and prosecutions across all product types.
Geographic Distribution
Top 15 U.S. states by number of compliance actions. States with large pharmaceutical and medical device manufacturing footprints tend to receive the most enforcement activity.
Product Type & Center Breakdown
How compliance actions are distributed across FDA product categories and regulatory centers.
By Product Type
By FDA Center
Form 483 Citations — Overview
FDA Form 483 is issued to a company at the conclusion of an inspection when investigators have observed conditions that may constitute violations of the Food Drug and Cosmetic Act. Each citation references a specific CFR (Code of Federal Regulations) section.
Most Common 483 Observations
The most frequently cited CFR parts on Form 483 observations. These represent the regulatory areas where FDA inspectors most commonly find deficiencies.
| # | CFR Part | Description | Citations |
|---|
Top Companies — 483 Citations
The 10 companies receiving the most Form 483 citations. A high citation count often correlates with large manufacturing footprints and frequent FDA inspections.
Frequently Asked Questions
How many FDA warning letters are issued per year?
Loading…
What is a Form 483?
FDA Form 483 is a document issued by FDA investigators at the conclusion of an inspection when they have observed conditions that, in their judgment, may constitute violations of the Food Drug and Cosmetic Act and related regulations. It lists specific observations of objectionable conditions or practices. Companies typically have 15 business days to respond with corrective actions. A Form 483 is not a final FDA determination of violation — it is a notice of observations that may warrant further action.
What are the most common 483 observations?
Loading…
What happens after a warning letter?
After receiving a warning letter, a company is expected to respond within 15 working days with a plan to correct the cited violations. If the company fails to adequately address the issues, the FDA may escalate enforcement through seizures (physically taking violative products), injunctions (court orders to stop specific practices), consent decrees (legally binding agreements to take corrective action), or criminal prosecution in the most serious cases. The FDA publishes all warning letters on its website and tracks compliance responses.
Explore FDA Compliance Data Further
- Browse FDA warning letters by date
- Browse all FDA compliance actions — seizures, injunctions & more
- Browse FDA import refusals by firm and country
- Track FDA enforcement actions via API
- Query compliance actions & import refusals via API
- Related dashboards: FDA inspection statistics, FDA recall statistics
Get This Data via API
Access manufacturing and compliance data programmatically through the full FDA MCP toolset. Start free with 300 credits.
Get API Key — Free/api/stats/compliance endpoint.Disclaimer: This analysis is provided for informational purposes only and should not be used as the sole basis for regulatory decisions.